These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8189072)

  • 1. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
    López D; García-Hoyo R; López de Castro JA
    J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
    López D; Rojo S; Calvo V; López de Castro JA
    J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
    García-Peydró M; Martí M; López de Castro JA
    J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
    Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
    Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
    Calvo V; Rojo S; López D; Galocha B; López de Castro JA
    J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
    Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA
    Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
    Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
    Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
    Rojo S; López D; Calvo V; López de Castro JA
    J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
    Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
    J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
    Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
    J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
    Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
    Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation.
    López D; García-Hoyo R; García F; López de Castro JA
    Eur J Immunol; 1994 May; 24(5):1194-9. PubMed ID: 8181529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA-B27 molecular subtypes and spondylarthropathies].
    Tieng V; Charron D; Toubert A
    Pathol Biol (Paris); 1998 Dec; 46(10):737-40. PubMed ID: 9922989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity.
    Paradela A; García-Peydró M; Vázquez J; Rognan D; López de Castro JA
    J Immunol; 1998 Nov; 161(10):5481-90. PubMed ID: 9820524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
    Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
    J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
    Boisgérault F; Tieng V; Stolzenberg MC; Dulphy N; Khalil I; Tamouza R; Charron D; Toubert A
    J Clin Invest; 1996 Dec; 98(12):2764-70. PubMed ID: 8981922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.